글로벌 종합 대사 패널(CMP) 테스트 시장 – 2030년까지의 산업 동향 및 예측

종합 대사 패널(CMP) 테스트 시장 분석 및 규모

국제 당뇨병 재단과 미국 당뇨병 협회는 다양한 인식 캠페인과 다른 형태의 광고를 통해 당뇨병을 진단하고 모니터링하는 것의 중요성을 강조하는 가장 유명한 조직 중 두 곳입니다. 더욱이, 의료 진단의 풍경은 최근 몇 년 동안 개선된 진단 제품과 바이오마커의 도입으로 인해 근본적인 변화를 겪었습니다. 그러나 질병의 재발과 진행은 여전히 ​​높으며, 특히 노인 환자 사이에서 그렇습니다. 충족되지 않은 강력한 수요는 CMP 테스트 룸에서 일류의 획기적인 진단법을 개발할 수 있는 중요한 기회를 제공합니다.

Data Bridge Market Research는 2022년에 147억 7천만 달러였던 종합 대사 패널(CMP) 검사 시장이 2030년까지 279억 5천만 달러에 도달할 것으로 분석했으며, 2023년부터 2030년까지의 예측 기간 동안 8.3%의 CAGR을 기록할 것으로 예상합니다. Data Bridge Market Research에서 큐레이팅한 시장 보고서에는 시장 가치, 성장률, 세분화, 지리적 범위, 주요 업체와 같은 시장 시나리오에 대한 통찰력 외에도 심층 전문가 분석, 환자 역학, 파이프라인 분석, 가격 분석 및 규제 프레임워크도 포함됩니다.

종합 대사 패널(CMP) 테스트 시장 범위 및 세분화  

시장 정의

A comprehensive metabolic panel is a type of assessment designed to assist doctors in providing information about the body's fluid balance, kidney and liver function, and electrolyte levels. For this test, blood is usually drawn from a vein. It includes electrolytes, protein, kidney function, and liver function tests. It also aids in the tracking of disease symptoms and the side effects of drugs used in disease treatment.

Comprehensive Metabolic Panel (CMP) Testing Market Dynamics

Drivers

• Rising healthcare Industry

The healthcare industry is heavily dependent on regulatory frameworks established by organizations such as the Food and Drug Administration (FDA) in the United States and the European Medicines Agency in Europe (EMA). Clinical Laboratory Improvement Amendments (CLIA) regulate the approval of these tests, and government bodies set the fee waiver as well as Medicare and Medicaid reimbursement. The FDA has authority over Laboratory-Developed Tests (LDTs), tests developed in-house in clinical laboratories to provide efficient and rapid results. These are the certain factors which boots the market growth.

Opportunities

• Rising CMP testing

One of the major factors expected to drive the market for CMP testing is rising consumer awareness about healthcare. Many organizations around the world are working to raise awareness about diseases, available treatment options, and the advantages of early diagnosis and precautions. The International Diabetes Foundation and the American Diabetes Association, for example, are two key organizations that emphasize the critical importance of diagnosing and monitoring diabetes through various awareness campaigns and other forms of advertising.

Restraints/Challenges

• Lack of physical activity

A lack of physical activity among the population will accelerate market growth.  On the other hand, the ambiguous regulatory system, is expected to hamper the growth of the comprehensive metabolic panel (CMP) market in the coming years.

This comprehensive metabolic panel (CMP) testing market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the comprehensive metabolic panel (CMP) testing market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Global Comprehensive Metabolic Panel (CMP) Testing Market Scope

The comprehensive metabolic panel (CMP) testing market is segmented on the basis of disease, test type and end-user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Disease

• Kidney Disease
• Liver Disease
• Diabetes
• Others

Test Type

• Proteins
• Electrolytes
• Kidney Tests
• Liver Functional Tests
• Glucose

End-User

• Laboratories
• PoC

Comprehensive Metabolic Panel (CMP) Testing Market Regional Analysis/Insights

The comprehensive metabolic panel (CMP) testing market is analyzed and market size insights and trends are provided by country, disease, test type and end-user as referenced above.

The countries covered in the comprehensive metabolic panel (CMP) testing market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America dominates the comprehensive metabolic panel (CMP) testing market because of the rising public awareness about comprehensive metabolic panel and kidney diseases and the increasing geriatric population in the region in the coming years.

Asia-Pacific is expected to grow at the highest growth rate in the forecast period of 2023 to 2030 owing to the growing demand for comprehensive metabolic panel testing in the region during the forecast period.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.

Healthcare Infrastructure Growth Installed base and New Technology Penetration

종합 대사 패널(CMP) 테스트 시장은 또한 모든 국가에 대한 자세한 시장 분석을 제공합니다. 자본 장비에 대한 의료 지출 증가, 종합 대사 패널(CMP) 테스트 시장을 위한 다양한 종류의 제품 설치 기반, 라이프라인 곡선을 사용하는 기술의 영향, 의료 규제 시나리오의 변화 및 종합 대사 패널(CMP) 테스트 시장에 미치는 영향. 이 데이터는 2011-2021년의 과거 기간에 대해 제공됩니다.

경쟁 환경 및 종합 대사 패널(CMP) 테스트 시장 점유율 분석

종합 대사 패널(CMP) 테스트 시장 경쟁 구도는 경쟁자별 세부 정보를 제공합니다. 포함된 세부 정보에는 회사 개요, 회사 재무, 창출된 수익, 시장 잠재력, 연구 개발 투자, 새로운 시장 이니셔티브, 글로벌 입지, 생산 현장 및 시설, 생산 용량, 회사의 강점과 약점, 제품 출시, 제품 폭과 범위, 응용 프로그램 우위가 있습니다. 제공된 위의 데이터 포인트는 종합 대사 패널(CMP) 테스트 시장과 관련된 회사의 초점에만 관련이 있습니다.

종합 대사 패널(CMP) 테스트 시장에서 활동하는 주요 업체는 다음과 같습니다.

• Walk-In Lab, LLC (미국)
• 애벗(미국)
• Quest Diagnostics Incorporated(미국)
• Laboratory Corporation of America Holdings (미국)
• 유니패스(인도)
• Synlab 그룹(독일)
• 아바시스(미국)
• TCG, Inc. (미국)
• Scion Lab Services, LLC(미국)
• 센토진 NV(독일)

SKU-50111